Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

EPIDIOLEX (cannabidiol) for Seizures Associated with Lennox-Gastaut and Dravet Syndromes

Drug Name

EPIDIOLEX® (cannabidiol)

Developer

GW Pharmaceuticals

Therapy Class

AED Therapy

Current Indication

Lennox-Gastaut syndrome and Dravet syndrome

Market Sector

Genetics

Development Status

Approved in the US
Expand

Go Top